4//SEC Filing
Edwards Lifesciences Corp 4
Accession 0001225208-14-022193
$EWCIK 0001099800operating
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 6:29 PM ET
Size
15.7 KB
Accession
0001225208-14-022193
Insider Transaction Report
Form 4
Solomon Carlyn D
CVP, Critical Care & Vascular
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Acquire)
2014-10-28$85.45/sh−21,200$1,811,540→ 21,200 totalExercise: $85.45From: 2013-05-09Exp: 2019-05-08→ Common Stock (21,200 underlying) - Exercise/Conversion
Common Stock
2014-10-28$85.45/sh+21,200$1,811,540→ 91,954 total - Exercise/Conversion
Common Stock
2014-10-28$89.23/sh+39,600$3,533,508→ 70,754 total - Exercise/Conversion
Common Stock
2014-10-28$71.57/sh+11,850$848,104→ 103,804 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2014-10-28$89.23/sh−39,600$3,533,508→ 13,200 totalExercise: $89.23From: 2012-05-12Exp: 2018-05-11→ Common Stock (39,600 underlying) - Sale
Common Stock
2014-10-28$118.00/sh−72,650$8,572,751→ 31,154 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2014-10-28$71.57/sh−11,850$848,104→ 35,550 totalExercise: $71.57From: 2014-05-14Exp: 2020-05-13→ Common Stock (11,850 underlying)
Footnotes (2)
- [F1]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $117.69 to $118.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001099800
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 6:29 PM ET
- Size
- 15.7 KB